ShareIn commemoration of the 2024 World Diabetes Day, Merck Foundation, the philanthropic arm of Merck KGaA Germany, has ...

She previously served as Chief Executive Officer at Harpoon Therapeutics until the company's acquisition by Merck in early 2024 ... medicine has the potential to become an important new treatment ...

Vietnam Expands for 2025 with Addition of New Hall - The largest edition yet, nearly double the size of the 2023 edition. - ...

The event’s largest edition yet, nearly doubling the 2023 size, with Hall A1 fully booked six months in advance analytica ...

PRNewswire Singapore November 12 South-East Asia will now have its first dedicated Process Technology show with the launch of ...

Mestag Therapeutics ("Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions, today announced that it has expanded its leadership team with the appointments of Jan ...

CPHI & PMEC India will be hosting its 17th edition this year at the India Expo Centre, Greater Noida, Delhi-NCR. India’s ...

The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

Fintel reports that on November 15, 2024, Wolfe Research initiated coverage of Merck (NYSE:MRK) with a Peer Perform ...

Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks ’World Diabetes Day 2024’ together with Africa’s First Ladies, Ministries of Health, Medical Societies and Academia, through their ...

The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...